In the last 10 years, there has been significant development in computer simulation of pharmaceutical materials, processes and product performance. Gradually, more mechanistically based models are ...

Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially viable dosage forms, rarely a simple process. Image Credit: ...

AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...

PharmTech spoke with Dr. Asma Patel, VP Global Commercial and Scientific Consulting–Drug Product, to find out how the growth ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

Rohm and Haas’ Ion Exchange Resin Division is offering a new, comprehensive drug formulation service based on its Advanced Released Technologies, supported by its new FloVitro™ dissolution test ...

Patients with some cancers, autoimmune diseases, and metabolic disorders often endure time-consuming intravenous (IV) infusions to receive the best protein-based treatments available. Because these ...

Firms will offer integrated solutions for multiparticulate oral controlled-release products. Drug formulation and delivery specialists Bend Research and Catalent Pharma Solutions inked an agreement to ...

The protein therapeutics market totaled $63 billion in 2007 ($39 billion in the U.S. alone) and is expected to reach $87 billion by 2010, according to a report by Kalorama Information—“Protein ...

Sponsored by Specac LtdReviewed by Maria OsipovaOct 15 2025 Formulation scientists are behind the conversion of active pharmaceutical ingredients (API) into stable, bioavailable, and commercially ...